Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
49,714,617
-
Share change
-
+2,083,126
-
Total reported value
-
$5,557,318,660
-
Put/Call ratio
-
146%
-
Price per share
-
$111.80
-
Number of holders
-
660
-
Value change
-
+$248,431,833
-
Number of buys
-
265
-
Number of sells
-
294
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2019
As of 31 Mar 2019,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
660 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,714,617 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, GOLDMAN SACHS GROUP INC, CITIGROUP INC, DEUTSCHE BANK AG\, ROYAL BANK OF CANADA, Duquesne Family Office LLC, BNP PARIBAS ARBITRAGE, SA, and NATIXIS.
This page lists
663
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.